Skip to main content
. Author manuscript; available in PMC: 2022 Mar 7.
Published in final edited form as: J Med Chem. 2019 Feb 15;62(4):1989–1998. doi: 10.1021/acs.jmedchem.8b01541

Figure 3.

Figure 3.

Effects of NCC007 and longdaysin on kinase activities. (A) Profiling of NCC007 and longdaysin toward 57 kinases. (B) In vitro assay of CKIδ, CKIα, CDK2, CDK7, MAPK1, and MAPK3 to longdaysin, NCC007, and roscovitine. (C) Profiling of NCC007 toward 374 kinases. Kinases inhibited by >50% were highlighted in left.